Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Document type

Article

Version

Published version

Publication date

Publication license

cc-by (c) Williams, James P. et al., 2014
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/117328

HIV-1 DNA predicts disease progression and post-treatment virological control

Journal Title

Director/Tutor

Journal ISSN

Volume Title

Abstract

In HIV-1 infection, a population of latently infected cells facilitates viral persistence despite antiretroviral therapy (ART). With the aim of identifying individuals in whom ART might induce a period of viraemic control on stopping therapy, we hypothesised that quantification of the pool of latently infected cells in primary HIV-1 infection (PHI) would predict clinical progression and viral replication following ART. We measured HIV-1 DNA in a highly characterised randomised population of individuals with PHI. We explored associations between HIV-1 DNA and immunological and virological markers of clinical progression, including viral rebound in those interrupting therapy. In multivariable analyses, HIV-1 DNA was more predictive of disease progression than plasma viral load and, at treatment interruption, predicted time to plasma virus rebound. HIV-1 DNA may help identify individuals who could safely interrupt ART in future HIV-1 eradication trials.

Citation

Citation

WILLIAMS, James P., et al. HIV-1 DNA predicts disease progression and post-treatment virological control. eLife. 2014. Vol. 3, num. e03821. ISSN 2050-084X. [consulted: 10 of August of 2026]. Available at: https://hdl.handle.net/2445/117328

Export metadata

JSON - METS

Share record